Federal Register / Vol. 69, No. 188 / Wednesday, September 29, 2004 / Rules and Regulations 58049

That airspace extending upward from the 

surface to and including 3,500 feet MSL 

within a 4.3-mile radius of Joplin Regional 

Airport. This Class D airspace area is 

effective during the specific dates and times 

established in advance by a Notice to 

Airmen. The effective date and time will 

thereafter be continuously published in the 

Airport/Facility Directory.

* * * * *

Paragraph 6002 Class E Airspace 

Designated as Surface Areas.

* * * * *

ACE MO E2 Joplin, MO 

Joplin Regional Airport, MO 

Lat. 37°09′07′′ N., long. 94°29′54′′ W.)

Within a 4.3-mile radius of Joplin Regional 

Airport. This Class E airspace area is effective 

during the specific dates and times 

established in advance by a Notice to 

Airmen. The effective date and time will 

thereafter be continuously published in the 

Airport/Facility Directory.

* * * * *

Paragraph 6005 Class E airspace areas 

extending upward from 700 feet or more 

above the surface of the earth.

* * * * *

ACE MO E5 Joplin, MO 

Joplin regional Airport, MO 

(Lat. 37°09′07′′ N., long. 94°29′54′′ W.) 

LUNNS LOM 

(Lat. 37°12′11′′ N., long 94°33′31′′ W.)

That airspace extending upward from 700 

feet above the surface within a 6.8-mile 

radius of Joplin Regional Airport and within 

1.9 miles each side of the 318° bearing from 

the LUNNS LOM extending from the 6.8-mile 

radius of the airport to 7 miles northwest of 

the LOM.

* * * * *

Issued in Kansas City, MO, on September 

17, 2004. 

Paul J. Sheridan, 

Manager, Air Traffic Division, Central Region.

[FR Doc. 04–21862 Filed 9–28–04; 8:45 am] 

BILLING CODE 4910–13–M

DEPARTMENT OF COMMERCE

Bureau of Industry and Security 

15 CFR Part 744 

[Docket No. 040713207–4207–01] 

RIN 0694–AD13 

India: Removal of Indian Entity and 

Revision in License Review Policy for 

Certain Indian Entities; and a 

Clarification; Correction

AGENCY: Bureau of Industry and 

Security, Commerce.

ACTION: Final rule.

SUMMARY: On September 22, 2004, the 

Bureau of Industry and Security 

published a Federal Register document 

that, inter alia, removed an Indian entity 

from the Entity List and revised 

licensing policies for other Indian 

entities in the Export Administration 

Regulations. That notice was 

misprinted, containing typographical 

errors in the statement of licensing 

policy with respect to two Indian 

Department of Atomic Energy entities 

that are subject to International Atomic 

Energy Agency safeguards and in 

statements of Federal Register citations 

amending the Entity List. Additionally, 

the preamble in that notice should have 

stated that the licensing policy for the 

‘‘balance of plant’’ portion of Indian 

nuclear facilities subject to International 

Atomic Energy Agency safeguards 

(Rajasthan 1 & 2 and Tarapur 1 & 2) is 

a presumption of approval for items not 

multilaterally controlled for nuclear 

proliferation reasons. This document 

corrects those errors.

DATES: This rule is effective September 

23, 2004.

FOR FURTHER INFORMATION CONTACT:

Eileen M. Albanese, Office of Exporter 

Services, Bureau of Industry and 

Security, telephone: (202) 482–0436.

List of Subjects in 15 CFR Part 744 

Exports, Reporting and recordkeeping 

requirements, Terrorism.

■ Accordingly, for the reasons set forth 

in the preamble, 15 CFR part 744 is 

amended as follows:

PART 744—[AMENDED]

■ 1. The authority citation for 15 CFR 

part 744 is revised to read as follows:

Authority: 50 U.S.C. app. 2401 et seq.; 50 

U.S.C. 1701 et seq.; 22 U.S.C. 3201 et seq.; 

42 U.S.C. 2139a; Sec. 901–911, Pub. L. 106–

387; Sec. 221, Pub. L. 107–56; E.O. 12058, 43 

FR 20947, 3 CFR, 1978 Comp., p. 179; E.O. 

12851, 58 FR 33181, 3 CFR, 1993 Comp., p. 

608; E.O. 12938, 59 FR 59099, 3 CFR, 1994 

Comp., p. 950; E.O. 12947, 60 FR 5079, 3 

CFR, 1995 Comp., p. 356; E.O. 13026, 61 FR 

58767, 3 CFR, 1996 Comp., p. 228; E.O. 

13099, 63 FR 45167, 3 CFR, 1998 Comp., p. 

208, E.O. 13222, 66 FR 44025, 3 CFR, 2001 

Comp., p. 783; E.O. 13224, 66 FR 49079, 3 

CFR, 2001 Comp., p. 786; Notice of October 

29, 2003, 68 FR 62209, 3 CFR, 2003 Comp., 

p. 347; Notice of August 6, 2004, 69 FR 48763 

(August 10, 2004).

§ 744.1 [Corrected]

■ 2. In Supplement No. 4 to part 744, 

under the country of ‘‘India’’, the entities 

‘‘Indian Space Research Organization 

(ISRO) headquarters in Bangalore’’ and 

‘‘Department of Atomic Energy Agency 

entities’’ are revised to read as follows:

SUPPLEMENT NO. 4 TO PART 744—ENTITY LIST

Country/Entity License requirement License review policy Federal Register citation 

* * * * * * * 

INDIA 

The following Indian Space Research Organization 

(ISRO) subordinate entities: 

—ISRO Telemetry, Tracking and Command Network (ISTRAC);.

—ISRO Inertial Systems Unit (IISU), 

Thiruvananthapuram;.

—Liquid Propulsion Systems Center; .....................

—Solid Propellant Space Booster Plant (SPROB); 

—Space Applications Center (SAC), Ahmadabad;

—Sriharikota Space Center (SHAR); ......................

—Vikram Sarabhai Space Center (VSSC), 

Thiruvananthapuram.

For all items subject to the 

EAR having a classification other than (1) 

EAR99 or (2) a classification where the third 

through fifth digits of the 

ECCN are ‘‘999’’, e.g.

XX999.

Case-by-case review for all 

items on the CCL.

63 FR 64322, 11/19/98; 65 

FR 14444, 03/17/00; 66 

FR 50090, 10/01/01; 69 

FR 56694, 09/22/04. 

58050 Federal Register / Vol. 69, No. 188 / Wednesday, September 29, 2004 / Rules and Regulations 

SUPPLEMENT NO. 4 TO PART 744—ENTITY LIST—Continued

Country/Entity License requirement License review policy Federal Register citation 

The following Dpeartment of Atomic Energy entities: 

—Bhabha Atomic Research Center (BARC); .........

—Indira Gandhi Atomic Research Center (IGCAR); 

—Indian Rare Earths; ..............................................

—Nuclear reactors (including power plants) not 

under International Atomic Energy Agency 

(IAEA) safeguards, fuel reprocessing and enrichment facilities, heavy water production facilities 

and their collocated ammonia plants.

For all items subject to the 

EAR.

Case-by-case for all items 

listed on the CCL. Presumption of approval for 

EAR99 items.

63 FR 64322, 11/19/98; 65 

FR 14444, 03/17/00; 66 

FR 50090, 10/01/01; 69 

FR 56694, 09/22/04. 

The following Department of Atomic Energy entities: 

—Nuclear reactors (including power plants) subjet 

to International Atomic Energy Agency (IAEA) 

safeguards: Tarapur (TAPS 1 & 2), Rajasthan 

(RAPS 1 & 2).

For all items subject to the 

EAR.

Case-by-case for all items 

listed on the CCL. Presumption of approval for 

EAR99 items. Presumption of approval for all 

items not multilaterally 

controlled for Nuclear 

Proliferation (NPI) reasons for use in the ‘‘balance of plant’’ (non-reactor-related end uses) 1

activities at nuclear facilities subject to International Atomic Energy 

Agency safeguards 

(Rajasthan 1 & 2 and 

Tarapur 1 & 2).

63 FR 64322, 11/19/98; 65 

FR 14444, 03/17/00; 66 

FR 50090, 10/01/01; 69 

FR 56694, 09/22/04. 

* * * * * * * 

1 ‘‘Balance of Plant’’ refers to the part of a nuclear power plant used for power generation (e.g., turbines, controllers, or power distribution) to 

distinguish it from the nuclear reactor. 

Eileen M. Albanese, 

Director, Office of Exporter Services.

[FR Doc. 04–21837 Filed 9–27–04; 11:43 am] 

BILLING CODE 3510–33–P

DEPARTMENT OF JUSTICE

Drug Enforcement Administration 

21 CFR Part 1308 

[Docket No. DEA–252F] 

Schedules of Controlled Substances: 

Placement of Alpha-Methyltryptamine 

and 5-Methoxy-N,NDiisopropyltryptamine Into Schedule I 

of the Controlled Substances Act

AGENCY: Drug Enforcement 

Administration (DEA), Department of 

Justice.

ACTION: Final rule.

SUMMARY: This final rulemaking is 

issued by the Deputy Administrator of 

the Drug Enforcement Administration 

(DEA) to place alpha-methyltryptamine 

(AMT) and 5-methoxy-N,Ndiisopropyltryptamine (5-MeO-DIPT) 

into Schedule I of the Controlled 

Substances Act (CSA). This action by 

the DEA Deputy Administrator is based 

on a scheduling recommendation by the 

Department of Health and Human 

Services (DHHS) and a DEA review 

indicating that AMT and 5-MeO-DIPT 

meet the criteria for placement in 

Schedule I of the CSA. This final rule 

will continue to impose the regulatory 

controls and criminal sanctions of 

Schedule I substances on the 

manufacture, distribution, and 

possession of AMT and 5-MeO-DIPT.

EFFECTIVE DATE: September 29, 2004.

FOR FURTHER INFORMATION CONTACT:

Christine Sannerud, PhD, Chief, Drug 

and Chemical Evaluation Section, Office 

of Diversion Control, Drug Enforcement 

Administration, Washington, DC 20537, 

Telephone (202) 307–7183.

SUPPLEMENTARY INFORMATION: On April 

4, 2003, the Deputy Administrator of the 

DEA published a final rule in the 

Federal Register (68 FR 16427) 

amending § 1308.11(g) of Title 21 of the 

Code of Federal Regulations to 

temporarily place AMT and 5-MeODIPT into Schedule I of the CSA 

pursuant to the temporary scheduling 

provisions of 21 U.S.C. 811(h). This 

final rule, which became effective on 

the date of publication, was based on 

findings by the Deputy Administrator 

that the temporary scheduling of AMT 

and 5-MeO-DIPT was necessary to avoid 

an imminent hazard to the public safety. 

Section 201(h)(2) of the CSA (21 U.S.C. 

811(h)(2)) requires that the temporary 

scheduling of a substance expires at the 

end of one year from the effective date 

of the order. However, if proceedings to 

schedule a substance pursuant to 21 

U.S.C. 811(a)(1) have been initiated and 

are pending, the temporary scheduling 

of a substance may be extended for up 

to six months. On March 31, 2004, the 

Acting Deputy Administrator published 

a notice of proposed rulemaking in the 

Federal Register (69 FR 16838) to place 

AMT and 5-MeO-DIPT into Schedule I 

of the CSA on a permanent basis. The 

temporary scheduling of AMT and 5-

MeO-DIPT, which would have expired 

April 3, 2004, was extended to October 

3, 2004 (69 FR 17034, April 1, 2004). 

One comment was received regarding 

the proposed placement of these 

substances into Schedule I of the CSA. 

The DEA has gathered and reviewed 

the available information regarding the 

pharmacology, chemistry, trafficking, 

actual abuse, pattern of abuse, and the 

relative potential for abuse for AMT and 

5-MeO-DIPT. The Acting Deputy 

Administrator submitted these data to 

the Acting Assistant Secretary for 

Health, Department of Health and 

Human Services (DHHS). In accordance 

with 21 U.S.C. 811(b), the Acting 

Deputy Administrator also requested a 

scientific and medical evaluation and a